Libya’s National Diabetes Authority has launched a unified electronic system to register diabetes patients and improve the distribution of medicines across the country.
The new platform was introduced in Tripoli on 30 April 2026, in the presence of government representatives, municipal mayors, diabetes centre directors, doctors and medical specialists.
According to the authority, the system is designed to create a national database for diabetes patients, regulate medicine distribution, and improve access to treatment, especially for patients who depend on insulin.
Awad Al-Gwairi, head of the National Diabetes Authority, said the platform represents a major step towards strengthening medicine security in Libya. He noted that linking insulin distribution to each patient’s national identification number would help ensure fairness, transparency and continuity of treatment for registered patients.
The technical team behind the system presented its operating mechanism, including patient data protection procedures, registration methods for remote areas, emergency case handling, and data integration between medical centres and the authority.
The authority confirmed that the system has officially begun operating in medical centres, describing it as part of wider efforts to modernise diabetes care and improve the management of chronic disease services in Libya.
The move comes as Libya continues to face pressure on its healthcare system, particularly in the supply and distribution of essential medicines. A unified digital platform could help reduce duplication, improve planning, and give health officials clearer data on patient needs across different regions.